The Nuclear Receptor News is a quarterly newsletter focusing on what is new and exciting in research, products and events related to NRs. Our first issue was released in June 2009 highlighting PPARgamma, an important target for anti-diabetic drugs. The second issue, released in December 2009 focused on FXR, a regulator of cholesterol and bile acid synthesis. The Spring 2010 Issue discusses the Nuclear Receptors involved in drug metabolism and toxicology. Control of reverse cholesterol transport, and important process in atherosclerosis, by NRs is discussed int he Summer 2010 release. 

If you wish to contribute to the NRN, please click on the "Contact NRR" link. Same goes if you wish to be put on our mailing list.